104 related articles for article (PubMed ID: 34910812)
1. Telomere Length Declines in Persons With Human Immunodeficiency Virus Before Antiretroviral Therapy Start but Not After Viral Suppression: A Longitudinal Study Over >17 Years.
Schoepf IC; Thorball CW; Ledergerber B; Kootstra NA; Reiss P; Raffenberg M; Engel T; Braun DL; Hasse B; Thurnheer C; Marzolini C; Seneghini M; Bernasconi E; Cavassini M; Buvelot H; Arribas JR; Kouyos RD; Fellay J; Günthard HF; Tarr PE
J Infect Dis; 2022 May; 225(9):1581-1591. PubMed ID: 34910812
[TBL] [Abstract][Full Text] [Related]
2. Impact of Delaying Antiretroviral Treatment During Primary Human Immunodeficiency Virus Infection on Telomere Length.
Raffenberg M; Engel T; Schoepf IC; Kootstra NA; Reiss P; Braun DL; Thorball CW; Fellay J; Kouyos RD; Ledergerber B; Günthard HF; Tarr PE; ;
J Infect Dis; 2021 Nov; 224(10):1775-1784. PubMed ID: 33822976
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic ageing accelerates before antiretroviral therapy and decelerates after viral suppression in people with HIV in Switzerland: a longitudinal study over 17 years.
Schoepf IC; Esteban-Cantos A; Thorball CW; Rodés B; Reiss P; Rodríguez-Centeno J; Riebensahm C; Braun DL; Marzolini C; Seneghini M; Bernasconi E; Cavassini M; Buvelot H; Thurnheer MC; Kouyos RD; Fellay J; Günthard HF; Arribas JR; Ledergerber B; Tarr PE;
Lancet Healthy Longev; 2023 May; 4(5):e211-e218. PubMed ID: 37148893
[TBL] [Abstract][Full Text] [Related]
4. Telomere Length, Traditional Risk Factors, Factors Related to Human Immunodeficiency Virus (HIV) and Coronary Artery Disease Events in Swiss Persons Living With HIV.
Engel T; Raffenberg M; Schoepf IC; Kootstra NA; Reiss P; Thorball CW; Hasse B; Hirzel C; Wissel K; Roth JA; Bernasconi E; Darling KEA; Calmy A; Fellay J; Kouyos RD; Günthard HF; Ledergerber B; Tarr PE;
Clin Infect Dis; 2021 Oct; 73(7):e2070-e2076. PubMed ID: 32725240
[TBL] [Abstract][Full Text] [Related]
5. Correlates of telomere length shortening in peripheral leukocytes of HIV-infected individuals and association with leukoaraiosis.
Minami R; Takahama S; Yamamoto M
PLoS One; 2019; 14(6):e0218996. PubMed ID: 31246986
[TBL] [Abstract][Full Text] [Related]
6. Leukocyte telomere length in HIV-infected pregnant women treated with antiretroviral drugs during pregnancy and their uninfected infants.
Imam T; Jitratkosol MH; Soudeyns H; Sattha B; Gadawski I; Maan E; Forbes JC; Alimenti A; Lapointe N; Lamarre V; Money DM; Côté HC;
J Acquir Immune Defic Syndr; 2012 Aug; 60(5):495-502. PubMed ID: 22580562
[TBL] [Abstract][Full Text] [Related]
7. Total HIV-1 DNA Dynamics and Influencing Factors in Long-Term ART-Treated Japanese Adults: A Retrospective Longitudinal Analysis.
Stanoeva KR; König A; Fukuda A; Kawanami Y; Kuwata T; Satou Y; Matsushita S
J Acquir Immune Defic Syndr; 2018 Jun; 78(2):239-247. PubMed ID: 29481485
[TBL] [Abstract][Full Text] [Related]
8. Determinants of blood telomere length in antiretroviral treatment-naïve HIV-positive participants enrolled in the NEAT 001/ANRS 143 clinical trial.
Alejos B; Stella-Ascariz N; Montejano R; Rodriguez-Centeno J; Schwimmer C; Bernardino JI; Rodes B; Esser S; Goujard C; Sarmento-Castro R; De Miguel R; Esteban-Cantos A; Wallet C; Raffi F; Arribas JR;
HIV Med; 2019 Nov; 20(10):691-698. PubMed ID: 31532902
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy.
Besson GJ; Lalama CM; Bosch RJ; Gandhi RT; Bedison MA; Aga E; Riddler SA; McMahon DK; Hong F; Mellors JW
Clin Infect Dis; 2014 Nov; 59(9):1312-21. PubMed ID: 25073894
[TBL] [Abstract][Full Text] [Related]
10. The pattern and magnitude of T cell subsets reconstitution during ten years of ART with viral suppression in HIV-infected patients.
Lu L; Li X; Liu X; Qiu Z; Han Y; Song X; Li Y; Li X; Cao W; Lv W; Dou Z; Li T
Aging (Albany NY); 2022 Dec; 14(23):9647-9667. PubMed ID: 36490352
[TBL] [Abstract][Full Text] [Related]
11. Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy.
Le T; Wright EJ; Smith DM; He W; Catano G; Okulicz JF; Young JA; Clark RA; Richman DD; Little SJ; Ahuja SK
N Engl J Med; 2013 Jan; 368(3):218-30. PubMed ID: 23323898
[TBL] [Abstract][Full Text] [Related]
12. No difference in the rate of change in telomere length or telomerase activity in HIV-infected patients after three years of darunavir/ritonavir with and without nucleoside analogues in the MONET trial.
Solomon A; Tennakoon S; Leeansyah E; Arribas J; Hill A; Van Delft Y; Moecklinghoff C; Lewin SR
PLoS One; 2014; 9(11):e109718. PubMed ID: 25368992
[TBL] [Abstract][Full Text] [Related]
13. The association between telomere length and non-alcoholic fatty liver disease: a prospective study.
Tang L; Li D; Ma Y; Cui F; Wang J; Tian Y
BMC Med; 2023 Nov; 21(1):427. PubMed ID: 37940980
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled pilot trial of valacyclovir for attenuating inflammation and immune activation in HIV/herpes simplex virus 2-coinfected adults on suppressive antiretroviral therapy.
Yi TJ; Walmsley S; Szadkowski L; Raboud J; Rajwans N; Shannon B; Kumar S; Kain KC; Kaul R; Tan DH
Clin Infect Dis; 2013 Nov; 57(9):1331-8. PubMed ID: 23946220
[TBL] [Abstract][Full Text] [Related]
15. Shorter telomere length predicts poorer immunological recovery in virologically suppressed HIV-1-infected patients treated with combined antiretroviral therapy.
Blanco JR; Jarrin I; Martinez A; Siles E; Larrayoz IM; Cañuelo A; Gutierrez F; Gonzalez-Garcia J; Vidal F; Moreno S;
J Acquir Immune Defic Syndr; 2015 Jan; 68(1):21-9. PubMed ID: 25321176
[TBL] [Abstract][Full Text] [Related]
16. HIV sequence diversity during the early phase of infection is associated with HIV DNA reductions during antiretroviral therapy.
Wang N; Li Y; Han Y; Xie J; Li T
J Med Virol; 2017 Jun; 89(6):982-988. PubMed ID: 27791274
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with CD8+ T-cell activation in HIV-1-infected patients on long-term antiretroviral therapy.
Zheng L; Taiwo B; Gandhi RT; Hunt PW; Collier AC; Flexner C; Bosch RJ
J Acquir Immune Defic Syndr; 2014 Oct; 67(2):153-60. PubMed ID: 25072610
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical study.
Massanella M; Bender Ignacio RA; Lama JR; Pagliuzza A; Dasgupta S; Alfaro R; Rios J; Ganoza C; Pinto-Santini D; Gilada T; Duerr A; Chomont N;
Lancet Microbe; 2021 May; 2(5):e198-e209. PubMed ID: 35544209
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical study.
Massanella M; Ignacio RAB; Lama JR; Pagliuzza A; Dasgupta S; Alfaro R; Rios J; Ganoza C; Pinto-Santini D; Gilada T; Duerr A; Chomont N
Lancet Microbe; 2021 May; 2(5):e198-e209. PubMed ID: 34841369
[TBL] [Abstract][Full Text] [Related]
20. Polygenic Risk Scores for Prediction of Subclinical Coronary Artery Disease in Persons With Human Immunodeficiency Virus (HIV): The Swiss HIV Cohort Study.
Schoepf IC; Thorball CW; Kovari H; Ledergerber B; Buechel RR; Calmy A; Weber R; Kaufmann PA; Nkoulou R; Schwenke JM; Braun DL; Fellay J; Tarr PE;
Clin Infect Dis; 2023 Jan; 76(1):48-56. PubMed ID: 36097729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
